Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucoside xylosyltransferase 1 pseudogene 4 (GXYLT1P4) is classified as a pseudogene, specifically related to the functional gene glucoside xylosyltransferase 1 (GXYLT1). Pseudogenes are segments of DNA that resemble functional genes but are generally non-coding and not translated into functional proteins. There is no evidence that GXYLT1P4 encodes an active receptor, enzyme, transporter, or other protein product, nor is it considered a direct therapeutic target. Most available scientific information pertains only to the functional GXYLT1 gene, not its pseudogenes[1][2][3][4][5]. Therefore, GXYLT1P4 is not a drug target, and there are no known biological functions, disease associations, or interacting drugs specific to this pseudogene. Note: If you are interested in the functional gene (GXYLT1), that is an enzyme involved in glycosylation of epidermal growth factor repeats and modulation of Notch signaling, with links to tumorigenesis and developmental processes[1][3][5]. However, "GXYLT1P4" itself is not a functional protein-coding gene and thus not relevant as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucoside xylosyltransferase 1 pseudogene 4 (GXYLT1P4).